P
0.960
-0.12 (-11.08%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | PDS Biotechnology Corporation | 混合的 | 看跌 |
AIStockmoo 评分
0.4
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | 0.5 |
| 平均 | 0.38 |
|
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 3.09% |
| 机构持股比例 | 18.11% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Inspirion Wealth Advisors, Llc | 31 Mar 2026 | 181,995 |
| Iron Gate Global Advisors Llc | 31 Dec 2025 | 75,016 |
| Tempus Wealth Planning, Llc | 31 Dec 2025 | 61,800 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合